7654465111

List of Trials

Send Us A Message

Have questions for us? Contact us to find out more.

  • This field is for validation purposes and should be left unchanged.

Hematologic Malignancies

April 12, 2019

Vanda-VTR-297-1101-A Phase I multicenter, open label, dose-escalation study to determine the maximum tolerated does for Trichostatin A in subjects with replapsed or refractory Hematologic Malignancies.